Gene silencing of ATG4B, or, inhibiting ATG4B activity diminishes cancer cell viability and sensitizes cancer cell to chemotherapeutic drugs in vitro and in vivo suggesting ATG4B might play a role as tumor promoter [22, 26–29]. The gene discussed is ATG4B; the disease is cancer.